Accelerate Diagnostics, Inc Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Accelerate Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q4 2024.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $964K, a 29.3% decline year-over-year.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $4.38M, a 18.7% decline year-over-year.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2024 was $4.38M, a 18.7% decline from 2023.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.39M, a 49.3% decline from 2022.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 51.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.